All Conditions
Condition Guide

Multiple Sclerosis (MS)

Multiple sclerosis is a neurological condition where the immune system attacks the myelin sheath around nerves.2 Diagnosis combines clinical findings, MRI, and several tests.1

Written by Suman Konda, Clinical Pharmacist · Based on peer-reviewed sources · Editorial policy · Not medical advice

Last reviewed and updated: · How we check our content

What multiple sclerosis is

Multiple sclerosis is a neurological condition in which the immune system attacks myelin, the insulating sheath around nerve fibres, disrupting signal transmission. Symptoms depend on where damage occurs: visual disturbance, numbness or tingling, limb weakness, balance problems and profound fatigue.

Most people (around 85%) start with relapsing-remitting MS — attacks followed by recovery periods — though some transition to secondary progressive disease, and a minority have primary progressive MS with gradual worsening from onset. There is no single blood test that confirms MS: it is a clinical and radiological diagnosis.1

How MS is usually evaluated

Diagnosis uses the McDonald criteria (revised 2017), which require “dissemination in space” (lesions in at least two different parts of the central nervous system) and “dissemination in time” (evidence of disease activity at more than one point). The key investigations:

InvestigationWhat it shows
MRI brain and spineThe cornerstone; characteristic white-matter lesions — active ones enhance with gadolinium contrast
Lumbar puncture (CSF)Oligoclonal bands, present in 85–95% of MS patients; supports the diagnosis
Visual evoked potentialsDelayed conduction suggesting past optic neuritis

Blood tests serve the opposite purpose: excluding mimics. AQP4 antibodies identify neuromyelitis optica — treated quite differently, since some MS therapies can worsen it — MOG antibodies identify MOG antibody disease, and B12, ANA, Lyme and syphilis serology exclude nutritional, autoimmune and infectious lookalikes.4

Your next steps if MS is suspected

  1. Get a neurology referral. MS diagnosis needs specialist interpretation of MRI against the McDonald criteria — it is not a diagnosis to make from symptoms alone.
  2. Expect MRI of brain and spinal cord, often a lumbar puncture, and the blood panel that excludes mimics (B12, AQP4, MOG, ANA).
  3. Ask directly: do I meet the McDonald criteria, and have AQP4 and MOG antibodies been checked?
  4. Discuss disease-modifying therapy with your neurologist: the choice depends on your MS type and activity, and early treatment changes the long-term course.
  5. Establish an MRI monitoring rhythm to track silent disease activity between relapses.

Practical notes

MS is a relapsing condition, so a dated symptom diary is one of the most valuable things you can bring to a neurologist — what happened, how long it lasted, and whether it fully resolved. Episodes that come and go are the hallmark pattern, and precise dates help distinguish new relapses from old symptoms fluctuating. Keep MRI reports and discs in date order alongside the diary.

Because MS has no single confirming blood test, the tests you do have serve to exclude mimics — so their context matters. Note vitamin B12 and D supplements (which alter those levels), recent infections, vaccinations, and any steroids taken, since these affect both symptoms and results. A complete medicine list helps the neurologist interpret borderline findings.

In MS consultations, doctors commonly discuss vitamin D status, smoking (associated with worse MS outcomes), regular moderate exercise, heat sensitivity management and fatigue pacing — practical daily-life factors rather than generic advice. These support, but never replace, disease-modifying treatment where prescribed. Discuss what is realistic for your energy levels.

MS follow-up typically combines scheduled neurology reviews with periodic MRI scans to check for silent disease activity — new lesions can appear without symptoms. Blood monitoring is also routine on several disease-modifying therapies. Keep every scheduled scan and review even during stable stretches; in MS, the quiet periods are when monitoring matters most.

In India

An MRI brain scan in India typically costs in the ballpark of ₹6,000–₹12,000 depending on the centre and sequences used, while basic blood work to exclude mimics (B12, thyroid, inflammatory markers) generally runs into the hundreds per test — though prices vary by city and lab. MS is uncommon in India, so assessment is usually centred at larger neurology departments.

NABL-accredited labs in Indian metros handle the specialised antibody tests (AQP4, MOG) used to distinguish MS from its mimics, sometimes sending samples to reference labs. Home sample collection is available for routine monitoring bloods — and for every report, the reference range printed on your own report is the one that counts.

Frequently asked questions

How is multiple sclerosis diagnosed?

Through a combination of clinical symptoms, MRI showing characteristic lesions, and sometimes spinal fluid analysis — assessed against the McDonald criteria. There is no single blood test that confirms it.

Do blood tests have any role in MS?

Yes. Blood tests don’t diagnose MS but are used to exclude conditions that mimic it, such as vitamin B12 deficiency, thyroid disease, neuromyelitis optica and certain autoimmune or infectious conditions.

What are common early symptoms of MS?

Visual disturbance, numbness or tingling, limb weakness, balance problems and fatigue — often coming and going in episodes, which is a hallmark of the relapsing form.

What are the McDonald criteria?

The diagnostic standard (revised 2017): evidence of damage in more than one part of the central nervous system (dissemination in space) at more than one point in time (dissemination in time), established by clinical episodes together with MRI findings and, where needed, oligoclonal bands in spinal fluid.

Which conditions can mimic MS?

Vitamin B12 deficiency, neuromyelitis optica (AQP4 antibodies), MOG antibody disease, lupus, Sjögren’s syndrome, sarcoidosis, Lyme disease and syphilis. Distinguishing them matters because treatments differ — some MS therapies can worsen neuromyelitis optica.

My MRI shows lesions but I have no symptoms — is that MS?
Not on MRI alone — incidental white-matter spots are common and have many causes, from migraine to small-vessel changes. MS diagnosis requires the clinical pattern plus MRI findings meeting formal criteria. A neurologist interprets the scan in the context of your history — discuss what the radiologist's report means for you specifically.
Can numbness that comes and goes be an MS relapse?
Fluctuating numbness has many possible explanations — old MS symptoms can temporarily resurface with heat, fever or stress without it being a new relapse. Whether an episode counts as a relapse depends on its duration and pattern, which is a neurologist's judgment call. Log the dates and duration and report it promptly rather than deciding yourself.
Should people with MS avoid exercise?
Generally no — regular moderate exercise is associated with better function, mood and fatigue levels in MS, though heat sensitivity means some people need cooling strategies. The right type and intensity depend on your current disability level. Discuss an exercise plan with your neurologist or physiotherapist rather than avoiding activity altogether.
How do I tell a real relapse from a bad day?
This is genuinely difficult, even for experienced patients — transient worsening with heat, infection or stress (pseudo-relapse) is common. Duration is a key clue: symptoms persisting beyond 24 hours in the absence of fever or infection are more concerning. When in doubt, contact your neurology team promptly rather than waiting it out.

References

Sources cited on this page. PubMed links open the original abstract.

  1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. PMID 18970977 · doi:10.1016/S0140-6736(08)61620-7
  2. Jakimovski D, Bittner S, Zivadinov R, et al. Multiple sclerosis. Lancet. 2024;403(10422):183–202. PMID 37949093 · doi:10.1016/S0140-6736(23)01473-3
  3. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636. PMID 29576504 · doi:10.1016/S0140-6736(18)30481-1
  4. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. PMID 29275977 · doi:10.1016/S1474-4422(17)30470-2
Medical Disclaimer: For educational purposes only. Always consult a qualified healthcare professional for diagnosis and treatment.
Written and medically reviewed by Suman Konda, Clinical Pharmacist · Sources linked to PubMed · Not medical advice: see our disclaimer